Navigation Links
Impac Software Collaborates With the National Comprehensive Cancer Network to Improve Patient Care
Date:2/17/2009

SUNNYVALE, Calif., Feb. 17 /PRNewswire/ -- Impac Software, part of the Elekta Group, today announced its collaboration with the National Comprehensive Cancer Network (NCCN) to license NCCN's clinical care content to clinicians utilizing MOSAIQ(R), Impac's oncology electronic medical record (EMR).

MOSAIQ will be the first oncology EMR to embed an intelligent search engine that dynamically links to the NCCN Clinical Practice Guidelines in Oncology(TM). The NCCN Guidelines are used by clinicians to shape care recommendations covering 97 percent of all patients with cancer and are updated on a continual basis. The NCCN Guidelines, developed through an explicit review of evidence and recommendations from medical experts, address cancer detection, prevention and risk reduction, workup and diagnosis and treatment and supportive care.

In addition, MOSAIQ also will provide active access to the NCCN Drugs & Biologics Compendium(TM), which delineates uses of drugs and biologics in the care of patients with cancer, listing FDA-approved disease indications as well as off-label recommendations for use, and to the NCCN Chemotherapy Order Templates(TM).

"NCCN is looking forward to working with Impac Software to provide another important channel for distribution of the NCCN Guidelines," says William T. McGivney, PhD, NCCN Chief Executive Officer. "As a result, clinicians will be provided with ready access to the best possible treatment options to improve outcomes for all patients with cancer."

"Simplified, real-time access to NCCN's evidence-based clinical content is expected to enhance the delivery of standardized care and improve patient safety," says Joel Goldwein, M.D., Vice President of Medical Affairs for the Elekta Group. "Many of Impac's customers are NCCN Member Institutions; however simplifying access to NCCN's clinical content will significantly increase the use of NCCN Guidelines throughout Impac Software's existing customer base, and in hundreds of cancer care centers."

About MOSAIQ(R)

Fundamentally integrated to manage the nuances of both medical and radiation oncology charting, Impac Software's comprehensive EMR, MOSAIQ provides a clear, fast and flexible means of documenting patient information throughout the medical assessment and chemotherapy administration process. With the ability to include diagnostic images, lab results, and external documentation, MOSAIQ provides clinicians with a complete picture of patient care. For more information, visit www.impac.com/mosaiq.

About Impac Software

Impac Software is part of the Elekta Group, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. Impac's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as systems for anatomic pathology, clinical laboratory and cancer registry.

Today, Elekta solutions are used in more than 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group. Elekta employs around 2,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information, please visit www.impac.com or www.elekta.com.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit www.nccn.org.


'/>"/>
SOURCE Impac Software
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets
2. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
3. Special Olympics Issues Report on the Impact of Special Olympics Healthy Athletes Initiative to show Need for Reauthorization of the Special Olympics Sport and Empowerment Act of 2004
4. Green Planet Wellness Helps Employers Have Big Environmental Impact
5. PJTV Holds Hearing on Stimulus Bill and Health Care Impacts
6. Pregnancy has no impact on breast cancer, but can delay diagnosis and treatment
7. Study finds pregnancy has no impact on breast cancer survival, delays treatment, diagnosis
8. Impact of narcotics is greater on mentally ill
9. Psychological impact found in adolescents with kidney transplants
10. MSU study finds high level of medical mistrust among minority women impacts quality of health care
11. BurrellesLuce IT Expert to Explore Web 3.0's Potential PR Impact At February Luncheon Meeting of Westchester/Fairfield PRSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor ... I/II HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental are now ... fear and require sedation to receive dental care. The doctors offer three treatment options ... hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites ... defects research related to Zika virus during pregnancy, as well as other prenatal ... important science. , The Teratology Society is an international and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: